Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
NCT ID: NCT01914289
Last Updated: 2016-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2011-01-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma
NCT05796700
Laparoscopic Hepatectomy Versus Open Hepatectomy for PHC
NCT02014025
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
NCT04365751
The China Laparoscopic Right Hemicolectomy SNAPSHOT
NCT04628182
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
NCT01862276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current therapies for the treatment of ICC are ineffective and the role of liver transplantation is not well defined.
This study reviews our experience with this tumor and looks for preoperative and pathologic indices that may help determine long term prognosis
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resection
To observe prognosis of resection of icc
Resection
Radiotherapy
Radiotherapy
To observe the prognosis of radiotherapy treatment of icc
Resection
Radiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resection
Radiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
No dysfunction in major organs; Blood routine, kidney function, cardiac function and lung function are basically normal. Hbg ≥ 90g/L, WBC ≥ 3.000 cells/mm³,platelets ≥ 80.000 cells/mm³.
Karnofsky Performance Score performance over 60. Patients who can understand this trial and have signed information consent.
Exclusion Criteria
Patients with other diseases which may affect the treatment mentioned here. Patients with medical history of other malignant tumors. Subjects participating in other clinical trials. Extrahepatic metastasis, portal vein or other major vascular involvement. liver function: Child B C.
Patients would not sign the consent to the trial.
17 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eastern Hepatobiliary Surgery Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ShenFeng
director of department of special treatment
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Aijun, MD
Role: STUDY_CHAIR
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eastern Hepatobiliary Surgery Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EHBH-RCT-2013-002-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.